D. Merkler

Discipline

Psychologie (1)

Type de document

Articles (12) Recensions (2)

Co-auteur

Date

Source

Mot-clé

Human beings (7) Cells (7) Mice (6) Treatment (5) Diseases (5) dommage (4) Diseases (4) T cells (4) Multiple sclerosis (4) Animals (4) puits (3) virus (3) spectacle (3) modèle (3) infection (3) maladie (3) cancer (3) Development (3) Cancer (3) Protection (3) Infection (3) Expression (3) Example (3) Central nervous system (3) Cancer (3) Antigens (3) Protection (3) maladie (3) temps (durée) (2) thérapie (2)

Documents écrit par D. Merkler (12) | parle de D. Merkler (0)

The alarmin interleukin-33 promotes the expansion and preserves the stemness of Tcf-1+ CD8+ T cells in chronic viral infection.
A.F. Marx et al. (11 avr. 2023)
Endothelial cell-derived oxysterol ablation attenuates experimental autoimmune encephalomyelitis.
F. Ruiz et al. (6 mars 2023)
Towards a national strategy for digital pathology in Switzerland.
A. Janowczyk et al.
Neurodegenerative phagocytes mediate synaptic stripping in Neuro-HIV.
G. Di Liberto et al. (27 août 2022)
IFN-γ-dependent tumor-antigen cross-presentation by lymphatic endothelial cells promotes their killing by T cells and inhibits metastasis.
L. Garnier et al. (10 juin 2022)
PPARɣ drives IL-33-dependent ILC2 pro-tumoral functions.
G. Ercolano et al. (5 mai 2021)
The Swiss Multiple Sclerosis Registry (SMSR): study protocol of a participatory, nationwide registry to promote epidemiological and patient-centered MS research.
N. Steinemann et al. (13 août 2018)
Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients.
P.H. Lalive et al. (24 juil. 2017)
Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy.
S.M. Kallert et al. (26 mai 2017)
pMHC affinity controls duration of CD8+ T cell-DC interactions and imprints timing of effector differentiation versus expansion.
A.J. Ozga et al. (14 nov. 2016)
Immunological mechanism of action and clinical profile of disease-modifying treatments in multiple sclerosis.
R.A. Du Pasquier et al. (2014)
Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection.
S. Enouz et al. (2012)